Abasaglar KwikPen 100 U/ml solution injectable Suïssa - francès - Swissmedic (Swiss Agency for Therapeutic Products)

abasaglar kwikpen 100 u/ml solution injectable

eli lilly (suisse) sa - insulinum glarginum - solution injectable - insulinum glarginum 3.64 mg corresp. insulinum glarginum 100 u., glycerolum, zinci oxidum, acidum hydrochloridum dilutum, natrii hydroxidum corresp. natrium 0.04 mg, metacresolum, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - diabète sucré - biotechnologika

Toujeo SoloStar 300 unités/ml solution injectable en stylo pré-rempli Suïssa - francès - Swissmedic (Swiss Agency for Therapeutic Products)

toujeo solostar 300 unités/ml solution injectable en stylo pré-rempli

sanofi-aventis (suisse) sa - insulinum glarginum - solution injectable en stylo pré-rempli - insulinum glarginum 10.91 mg corresp. insulinum glarginum 300 u., zinci chloridum, glycerolum (85 per centum), acidum hydrochloridum concentratum, natrii hydroxidum q.s. ad ph, metacresolum, aqua ad iniectabile ad solutionem pro 1 ml. - diabète sucré - biotechnologika

Insulin NovoNordisk NovoRapid PumpCart 100 E/ml Solution injectable Suïssa - francès - Swissmedic (Swiss Agency for Therapeutic Products)

insulin novonordisk novorapid pumpcart 100 e/ml solution injectable

novo nordisk pharma ag - insulinum aspartum - solution injectable - insulinum aspartum 100 u., glycerolum, zinci chloridum, dinatrii phosphas dihydricus, natrii chloridum, natrii hydroxidum, acidum hydrochloridum, phenolum, metacresolum, aqua ad iniectabile ad solutionem pro 1 ml corresp. natrium 3.216 mg. - le diabète sucré - biotechnologika

Fiasp ultra-fast-acting FlexTouch Solution injectable Suïssa - francès - Swissmedic (Swiss Agency for Therapeutic Products)

fiasp ultra-fast-acting flextouch solution injectable

novo nordisk pharma ag - insulinum aspartum - solution injectable - insulinum aspartum 600 nmol corresp. insulinum aspartum 100 u., glycerolum, zincum ut zinci acetas dihydricus, dinatrii phosphas dihydricus, arginini hydrochloridum, nicotinamidum, conserv.: phenolum 1.5 mg, metacresolum 1.72 mg, aqua ad iniectabile, q.s. ad solutionem pro 1 ml. - le diabète sucré - biotechnologika

Fiasp ultra-fast-acting Penfill Solution injectable Suïssa - francès - Swissmedic (Swiss Agency for Therapeutic Products)

fiasp ultra-fast-acting penfill solution injectable

novo nordisk pharma ag - insulinum aspartum - solution injectable - insulinum aspartum 600 nmol corresp. insulinum aspartum 100 u., glycerolum, zincum ut zinci acetas dihydricus, dinatrii phosphas dihydricus, arginini hydrochloridum, nicotinamidum, conserv.: phenolum 1.5 mg, metacresolum 1.72 mg, aqua ad iniectabile, q.s. ad solutionem pro 1 ml. - le diabète sucré - biotechnologika

Fiasp ultra-fast-acting Solution injectable Suïssa - francès - Swissmedic (Swiss Agency for Therapeutic Products)

fiasp ultra-fast-acting solution injectable

novo nordisk pharma ag - insulinum aspartum - solution injectable - insulinum aspartum 600 nmol corresp. insulinum aspartum 100 u., glycerolum, zincum ut zinci acetas dihydricus, dinatrii phosphas dihydricus, arginini hydrochloridum, nicotinamidum, conserv.: phenolum 1.5 mg, metacresolum 1.72 mg, aqua ad iniectabile, q.s. ad solutionem pro 1 ml. - le diabète sucré - biotechnologika

Suliqua 100/50 solution injectable Suïssa - francès - Swissmedic (Swiss Agency for Therapeutic Products)

suliqua 100/50 solution injectable

sanofi-aventis (suisse) sa - insulinum glarginum, lixisenatidum - solution injectable - insulinum glarginum 3.64 mg corresp. insulinum glarginum 100 u., lixisenatidum 50 µg, zinci chloridum, glycerolum (85 per centum), methioninum, conserv.: metacresolum 2.7 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - diabète sucré - biotechnologika

Suliqua 100/33 solution injectable Suïssa - francès - Swissmedic (Swiss Agency for Therapeutic Products)

suliqua 100/33 solution injectable

sanofi-aventis (suisse) sa - insulinum glarginum, lixisenatidum - solution injectable - insulinum glarginum 3.64 mg corresp. insulinum glarginum 100 u., lixisenatidum 33 µg, zinci chloridum, glycerolum (85 per centum), methioninum, conserv.: metacresolum 2.7 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - diabète sucré - biotechnologika

Fiasp 100 E/ml ultra-fast-acting PumpCart Solution injectable en Cartouche Suïssa - francès - Swissmedic (Swiss Agency for Therapeutic Products)

fiasp 100 e/ml ultra-fast-acting pumpcart solution injectable en cartouche

novo nordisk pharma ag - insulinum aspartum - solution injectable en cartouche - insulinum aspartum 6.15 mg corresp. insulinum aspartum 100 u., phenolum, metacresolum, glycerolum, zincum ut zinci acetas dihydricus, dinatrii phosphas dihydricus, arginini hydrochloridum, nicotinamidum, acidum hydrochloridum q.s. ad ph, natrii hydroxidum q.s. ad ph, aqua ad iniectabile, q.s. ad solutionem pro 1 ml corresp. natrium 6.15 mg. - le diabète sucré - biotechnologika

Awiqli FlexTouch 700 E/ml Solution injectable en stylo Prérempli Suïssa - francès - Swissmedic (Swiss Agency for Therapeutic Products)

awiqli flextouch 700 e/ml solution injectable en stylo prérempli

novo nordisk pharma ag - insulinum icodecum - solution injectable en stylo prérempli - insulinum icodecum 700 u., zincum ut zinci acetas, phenolum, metacresolum, glycerolum, natrii chloridum, acidum hydrochloridum ad ph, natrii hydroxidum ad ph, aqua ad iniectabile ad solutionem pro 1 ml corresp. natrium 0.46 mg. - behandlung des diabetes mellitus bei erwachsenen. - biotechnologika